Canaccord analyst George Gianarikas lowered the firm’s price target on Rivian (RIVN) to $21 from $23 and keeps a Buy rating on the shares. The firm noted the company lowered EBITDA guidance but the positives are that Reg credits are now gone, and earnings revisions may soon be nearing bottom. R2 is coming soon, and later this year management will be hosting an AI day to detail their approach to the age of autonomy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RIVN: